Roche presented eight Roche Idea Lab segments in the booth, in which experts discussed topics such as mass spectrometry, digital solutions, point of care, respiratory and STI testing, and the use of high-medical-value assays when treating Alzheimer’s disease, heart failure, and preeclampsia.
We gladly present replays of all the Roche Idea Lab sessions from ADLM 2024.
Artificial intelligence can assist in fostering a holistic approach to better care that moves beyond transactional operations. Hear the Roche-moderated conversation with Peter McCaffrey, chief AI officer for the University of Texas Medical Branch, on how navify® and other AI-driven solutions can unlock possibilities with cutting-edge algorithms.
Discover more about Roche's commitment to digital solutions.
Imagine a world where people with diabetes don’t experience heart failure progression — it could become a reality. In this video, Ibrahim A. Hashim, M.Sc., Ph.D., C.Sci., FIBMS, DABCC, FAACC, UT Southwestern Medical Center, discusses how to put the American Diabetes Association’s recommendation for heart failure risk monitoring in all people with diabetes into practice.
According to Dr. Hashim, subclinical (asymptomatic) heart failure is reversible, preventable and treatable. Laboratories are at the interface between patients and biomarker evaluation. Learn more about how the laboratory can be at the forefront of screening implementation, and how collaboration to conduct cardiac biomarker testing sooner can potentially save many from experiencing the devastating effects of heart failure.
Find out more about Roche's commitment to cardiometabolic care.
Mass spectrometry is a powerful tool for the clinical laboratory, notably for its high sensitivity, specificity and accuracy for better patient care. These strengths support mass spectrometry as the gold standard for many analytes and a main driver for adoption in the clinical laboratory. This Roche Idea Lab session features a conversation with Victoria Zhang, Ph.D., MBA, DABCC, University of Rochester Medical Center, on the medical value of mass spectrometry and provides specific case examples related to patient outcomes.
Discover more about Roche's commitment to mass spectrometry.
Effective and integrated point-of-care testing and treatment are essential to curb transmission rates for sexually transmitted infections (STIs) like chlamydia, gonorrhea and syphilis. Delve into a Roche-moderated conversation with Barbara Van Der Pol, MPH, Ph.D., University of Alabama at Birmingham, and Casey Pinto, Ph.D., NP, Penn State University, on the lab’s role in STIs, lifting stigma and how to talk to patients about STIs.
Discover more about Roche's commitment to STI diagnostics.
Black mothers are at a higher risk of developing pregnancy-related complications and hypertensive disorders, such as preeclampsia. Sarosh Rana, M.D., MPH, FACOG, University of Chicago Medicine, discusses the Black woman's experience with healthcare and the role diagnostics can play in improving outcomes for preeclampsia patients.
Learn more about the complexity of diagnosing and managing preeclampsia and how and when to put preeclampsia biomarkers — such as the SFlt-1/PlGF ratio — into practice based on both real-world and research-based evidence.
To learn more about the importance of diagnosing preeclampsia, watch Chaniece’s Story.
Find out more about Roche's commitment to women’s health.
In this session, Leslie Shaw, Ph.D., University of Pennsylvania, discusses how the availability of Alzheimer's biomarkers in CSF and blood is revolutionizing the diagnostic path. Early detection of Alzheimer’s disease (AD) pathology can occur in vivo using fluid biomarkers and/or Positron emission tomography (PET) imaging. The FDA approved/cleared cerebrospinal fluid (CSF) ratios can detect AD amyloid pathology early in the disease and correlate with amyloid PET. With the availability of amyloid removal therapies, which slow down cognitive decline, it is expected that laboratories will be faced with increased requests for AD testing.
Discover more about Roche's commitment to Alzheimer’s Disease.
From declining reimbursements to increasing business expenses and staff shortages, today’s diagnostic laboratories face pressures from all directions. However, lab managers and leaders can maximize efficiency and help improve the bottom line in many ways. Steve Serota and Robin Herbner at Wisconsin Diagnostic Laboratories share ideas on how labs can remain competitive by utilizing existing capacity and improving access for patients in support of optimized clinical care.
Discover more about Roche's commitment to the value of diagnostics.
Leaders from Vanderbilt Health discuss their organization's strategies to implement tenets of diagnostic stewardship into their respiratory testing algorithms to improve patient care. Learn from David C. Gaston, M.D., Ph.D., and Alisa Ezell, MHA, MLS (ASCP)CM, on how they did it.
Discover more about Roche's commitment to respiratory diagnostics.
Why choose Roche as your trusted partner? In a word — experience.
With nearly 130 years of driving the transformation of healthcare, Roche combines unparalleled experience and expertise to fully understand and simplify the complexities of the lab, and together deliver faster, more personalized patient care.
As the global leader for in-vitro diagnostics, we are driven by the responsibility to meet even the most complex patient needs with cutting-edge science and industry-leading technology. Through robust investments in research and development, we deliver transformational solutions that pave the way for a more productive and sustainable future in healthcare.
At Roche Diagnostics, we bring cutting-edge products and assays to market, ensuring the right test is available at the right time. We excel in clinical and digital transformation to help address critical healthcare needs when and where they matter most.
Science-driven leadership serves as the foundation of our unwavering commitment to help deliver the future of healthcare. Our cutting-edge systems and high-quality assays provide out clinical partners with the right test at the right time, enabling the right diagnoses for more patient-centric care.
Our transformative digital solutions address the world’s most critical healthcare needs with rigorous research and new product development, advancing more precise patient care when and where it matters most. A rich history of trustworthy transformation grounded in clinical evidence delivers unique, industry-leading credibility and benefits to our customers, our laboratory and clinical partners—and especially, the patients we serve together.
We focus on bringing simplicity to the laboratory, allowing our customers to do more with less. We continue to invest in growing our portfolio of integrated systems and data solutions to optimize resources and expedite care.
Simplicity is the cornerstone of our commitment to help customers do more with less. Our expansive portfolio of advanced, seamlessly-integrated physical and digital products ensures clinical excellence, facilitating fast and accurate diagnoses that are the foundation of outstanding patient care. Our easy-to-use products optimize operations and reduce the burden on laboratory personnel, enabling them to collaborate more effectively and efficiently in delivering trusted, timely test results. Streamlined logistics help keep customer labs running smoothly, so they can deliver uninterrupted patient care.
Through our deep commitment to customers and patients, we advance value-based care and ensure that our partnerships contribute to positive healthcare outcomes. Together, we provide seamless interactions between labs and clinicians to deliver an unmatched experience.
Patient-centric partnership are what empowers us to deliver personalized care to patients and our laboratory and provider customers. Our products are designed to facilitate seamless collaboration and interactions to help prevent problems from occurring, and to promptly address them when they do occur.
This approach simplifies the operational burdens of conducting daily business for the laboratory, allowing more time and attention to focus on delivering excellent, reliable results and, ultimately, greater patient satisfaction. Our comprehensive support model, mobilized by dedicated healthcare experts and advanced digital solutions, delivers an unmatched experience. Collaboration between Roche and its customers optimizes value-based care that helps improve patient lives.
If you would like to be contacted by a Roche representative in your region, check the box below.
